Check-Cap (NASDAQ:CHEK) Share Price Crosses Below 50-Day Moving Average – Time to Sell?

Check-Cap Ltd. (NASDAQ:CHEK)’s share price crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $1.57 and traded as low as $1.50. Check-Cap shares last traded at $1.6150, with a volume of 58,962 shares.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on CHEK shares. Wall Street Zen raised shares of Check-Cap to a “hold” rating in a research note on Saturday, November 15th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Check-Cap in a research report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has a consensus rating of “Sell”.

Check-Cap Stock Up 2.2%

The firm has a 50-day moving average of $1.57 and a two-hundred day moving average of $1.27. The company has a market capitalization of $9.45 million, a PE ratio of -0.58 and a beta of 0.41.

About Check-Cap

Check-Cap Ltd. (NASDAQ: CHEK) is a clinical-stage medical device company focused on the development of non-invasive screening technologies for colorectal cancer. The company’s lead product, the C-Scan® system, is designed to provide a full-colonic 360° visualization by combining an ingestible X-ray emitting capsule with an external detector array and proprietary image reconstruction algorithms. Intended as a minimally invasive alternative to traditional colonoscopy, the C-Scan system aims to improve patient comfort and compliance while maintaining high sensitivity for detecting polyps and early-stage lesions.

The C-Scan procedure involves the patient ingesting the capsule, which passes naturally through the gastrointestinal tract.